Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Vaccine-preventable diseases are a major source of morbidity and mortality in patients with altered immune competence. Patients with IBD are considered to be significantly immunocompromised hosts, mainly because of the immunomodulatory medications they take. Routine and specific immunizations are important to consider in this population. Whenever possible, immunization should be considered prior to administering any immunomodulator in order to optimize the immunological response. Prior to foreign travel, IBD patients are best advised by travel medicine specialists familiar with this complex and vulnerable population.


Journal article


Inflammatory Bowel Disease Monitor

Publication Date





106 - 110